The Generic Pharmaceutical Association says that savings from the use of generic prescription drugs has risen to the rate of nearly $1 billion every two days, totaling $193 billion in 2011 and more than $1 trillion in the last decade.

The GPhA commissioned the IMS Institute for Healthcare Informatics, a division of IMS Health, for an independently conducted study, which showed generic savings for consumers and the U.S. health care system grew 22% from 2010 to last year, the largest single-year jump since 1998.

Register or login for access to this item and much more

All Employee Benefit News content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access